Downregulation of telomerase activity in malignant lymphomas by radiation and chemotherapeutic agents.

被引：0
|
作者：
Lin, ZS
Lim, S
Viani, MA
Sapp, M
Lim, MS
机构：
[1] Univ Toronto, Sunnybrook & Womens Coll, Hlth Sci Ctr, Dept Pathol, Toronto, ON, Canada
[2] Univ Utah, ARUP Labs, Dept Pathol, Salt Lake City, UT USA
来源：
BLOOD | 2000年 / 96卷 / 11期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
4421
引用
收藏
页码：165B / 165B
页数：1
相关论文
共 50 条
  • [21] Spectroscopic studies on intercalating and minor groove binding chemotherapeutic agents.
    Sharples, D
    TROPICAL MEDICINE & INTERNATIONAL HEALTH, 1996, 1 (06) : A23 - A24
  • [22] CellScan technology for in vitro prediction of tumor response to chemotherapeutic agents.
    Chaitchik, S
    Soritau, O
    Fisher, E
    Pelau, D
    Lazar, L
    Schiffenbauer, YS
    JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (16) : 165S - 165S
  • [23] The development of non-natural nucleotides as adjunctive chemotherapeutic agents.
    Berdis, A. J.
    Lee, I
    Zhang, X.
    Devadoss, B.
    ENVIRONMENTAL AND MOLECULAR MUTAGENESIS, 2007, 48 (07) : 609 - 609
  • [24] Telomerase activity in malignant melanoma
    Hitchcock, MG
    Joshi, M
    White, WL
    LABORATORY INVESTIGATION, 1996, 74 (01) : 231 - 231
  • [25] Telomerase activity in malignant mesothelioma
    Matthews, P
    Manasses, D
    Skinner, J
    Jones, CJ
    Wynford-Thomas, D
    Omidvar, N
    Attanoos, R
    JOURNAL OF PATHOLOGY, 2000, 190 : 55A - 55A
  • [26] Downregulation of telomerase activity in HL60 cells by differentiating agents is accompanied by increased expression of telomerase-associated protein
    Reichman, TW
    Albanell, J
    Wang, XN
    Moore, MAS
    Studzinski, GP
    JOURNAL OF CELLULAR BIOCHEMISTRY, 1997, 67 (01) : 13 - 23
  • [27] Telomerase activity by subtype in B cell lymphomas
    Ely, SA
    Chadburn, A
    Cesarman, E
    Knowles, DM
    LABORATORY INVESTIGATION, 1999, 79 (01) : 136A - 136A
  • [28] CHEMOTHERAPEUTIC-AGENTS CAUSE MALIGNANT TRANSFORMATION
    JONES, PA
    BENEDICT, WF
    CLINICAL RESEARCH, 1975, 23 (02): : A163 - A163
  • [29] Genome-wide approach to finding determinants of susceptibility to chemotherapeutic agents.
    Shukla, S
    Badner, J
    Cheng, C
    Bleibel, W
    Dolan, ME
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2005, 77 (02) : P4 - P4
  • [30] New methods for structural analysis of DNA-binding chemotherapeutic agents.
    Coury, JE
    McFailIsom, L
    Bottomley, LA
    Williams, LD
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 1996, 211 : 24 - CARB
12345